Gastric cancer is a deadly disease and remains the third leading cause of cancer-related
death worldwide. The 5-year overall survival rate of patients with early-stage localized …

Cancers of the gastrointestinal (GI) tract greatly contribute to the global cancer burden and
cancer-related death. Claudin-18.2 (CLDN18. 2), a transmembrane protein, is a major …

Abstract Background Circular RNAs (circRNAs) are a class of noncoding RNAs (ncRNAs)
and can modulate gene expression by binding to miRNAs; further, circRNAs have been …

In this study, we investigated the role of SERPINH1 in gastric cancer (GC) progression. GC
patient tissues show significantly higher SERPINH1 mRNA and protein levels than normal …

Gastric cancer (GC) is an aggressive malignancy with a high mortality rate and poor
prognosis, primarily caused by metastatic lesions. Improved understanding of GC metastasis …

Metastasis accounts for 90% of cancer-related deaths among the patients. The
transformation of epithelial cells into mesenchymal cells with molecular alterations can occur …

Solid tumors can be divided into benign solid tumors and solid malignant tumors in the
academic community, among which malignant solid tumors are called cancers. Cancer is …

Drug resistance is an important factor for treatment failure of gastric cancer. N6‐
methyladenosine (m6A) is the predominant mRNA internal modification in eukaryotes. The …

Gastric cancer is one of the most common malignant tumours worldwide. Genetic and
epigenetic alterations are key factors in gastric carcinogenesis and drug resistance to …

Background & Aims Helicobacter pylori (H pylori) infection is the main risk factor for gastric
cancer. The role of fibroblast growth factor receptors (FGRFs) in H pylori-mediated gastric …